Unicare Pharma Limited is a house of Nutrition. The journey started in 1990 with an aim to give an ideal nutritional supplement, that could prevent diseases.
" We believe in a quote: The doctor of future will no longer treat the human frame with drugs, but rather cure & prevent diseases through Nutrition" -Thomas Edison (Early 2oth century) "
Unicare Pharma Limited views its R&D capabilities as a vital component of its business strategy that will provide the company with a sustainable, long-term competitive advantage. The company today aims at path-breaking research with plans for commissioning its R&D center at Theni. We are building on company's strength of vertical integration in discovery research, process chemistry, active pharmaceutical ingredient production, formulation development, clinical development and regulatory filings.
The company has in-house development and medical teams to undertake product and clinical development tailored to the needs of the Indian market.
Unicare Pharma Limited provides quality health care worldwide by creating healthcare solutions, which directly affects the life of the common man.
We believe that "Milk Protein is the first food that your mother gave you". It has rendered you strong and continues to be the prime food. We have made research in "Milk Protein" and formulated various varieties for different applications. We vow to continue to make better products and continue to serve mankind.
We have developed sugar free "Milk Protein" formulations for Diabetes, Cancer, Pregnancy & Lactation, General Surgery, Orthopedics and many more.
To establish a chain of "Milk Protein" retail chain across the world.
To introduce Dermatology range using "Milk Protein & Fat" as a basic ingredient.
To pursue value-added collaborative relationships with academia, hospitals and other research-based organizations so that we can track our developmental activities as per the highest standards, in the shortest time and at the lowest cost.
To enrich a knowledge pool of accomplished scientists to leverage emerging opportunities so that we can broadly define what needs to be developed. By establishing a state-of-the-art research house for focused R & D activities we can be present over the entire chain of drug / molecule discovery and development.